GIF-0173 protects against cerebral infarction through DP1 receptor activation

Experimental Neurology

Volumn 219, Issue 2, 2009, Pages 481-491

  Thura, Min ^a   Hokamura, Kazuya ^a   Yamamoto, Seiji ^a   Maeda, Masahide ^b   Furuta, Kyoji ^b   Suzuki, Masaaki ^b,c   Ibaraki, Kyoko ^a   Umemura, Kazuo ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c RIKEN   (Japan)

Author keywords

DP1 receptor; GIF 0173; Glutamate; Intracellular calcium concentration; PGD2

Indexed keywords

CALCIUM; GIF 0173; GLUTAMIC ACID; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN RECEPTOR; PROTEIN DP1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN BLOOD FLOW; BRAIN INFARCTION; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; MALE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN INFARCTION; CALCIUM; CELL DEATH; CELLS, CULTURED; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; DANTROLENE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTAMIC ACID; HYDANTOINS; INFARCTION, MIDDLE CEREBRAL ARTERY; INTRACELLULAR FLUID; LACTONES; LASER-DOPPLER FLOWMETRY; MALE; N-METHYLASPARTATE; NEURONS; NEUROPROTECTIVE AGENTS; PLATELET AGGREGATION INHIBITORS; PROSTAGLANDIN D2; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN; SESQUITERPENES; SEVERITY OF ILLNESS INDEX; TETRAZOLIUM SALTS;

EID: 69749111676     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2009.06.019     Document Type: Article

References (29)

1. Choi D.W. Excitotoxic cell death. J. Neurobiol. 23 (1992) 1261-1276
2. Furuta K., Tomokiyo K., Satoh T., Watanabe Y., and Suzuki M. Designed prostaglandins with neurotrophic activities. Chem. Bio. Chem. 1 4 (2000) 283-286
3. Hata A.N., and Breyer R.M. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol. Ther. 103 (2004) 147-166
4. Hirata Y., Furuta K., Miyazaki S., Suzuki M., and Kiuchi K. Anti-apoptotic and pro-apoptotic effect of NEPP11 on manganese-induced apoptosis and JNK pathway activation in PC12 cells. Brain Res. 1021 (2004) 241-247
5. 2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83 (1995) 813-819
6. 2 mediates neuronal protection via the DP1 receptor. J. Neurochem. 92 (2005) 477-486
7. Lynch D.R., and Guttmann R.P. Excitotoxicity: perspectives based on N-methyl-d-aspartate receptor subtypes. J. Pharmacol. Exp. Ther. 300 (2002) 717-723
8. + exchanger inhibitor, SM-20220, is protective against excitotoxicity in cultured cortical neurons. Stroke 35 (2004) 185-190
9. 2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood 98 (2001) 1942-1948
10. Mukherjee D., Nissen S.E., and Topol E.J. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 286 (2001) 954-959
11. Nagai N., Yamamoto S., Tsuboi T., Ihara H., Urano T., Takada Y., Terakawa S., and Takada A. Tissue-type plasminogen activator is involved in the process of neuronal death induced by oxygen-glucose deprivation in culture. J. Cereb. Blood Flow Metab. 21 (2001) 631-634
12. 2 in rat brain, spinal cord and pituitary: basal level and regional distribution. Life Sci. 31 (1982) 2093-2103
13. Nogawa S., Zhang F., Ross M.E., and Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J. Neurosci. 17 (1997) 2746-2755
14. 2 DP1 receptor protects brain from ischemia-reperfusion injury. Eur. J. Neurosci. 26 (2007) 73-78
15. 2and its metabolites promote neurite outgrowth induced by nerve growth factor in PC12 Cells. Biochem. Biophys. Res. Commun. 258 (1999) 50-53
16. Satoh T., Furuta K., Tomokiyo K., Nakatsuka D., Tanikawa M., Nakanishi M., Miura M., Tanaka S., Koike T., Hatanaka H., Ikuta K., Suzuki M., and Watanabe Y. Facilitatory roles of novel compounds designed from cyclopentenone prostaglandins on neurite outgrowth-promoting activities of nerve growth factor. J. Neurochem. 75 (2000) 1092-1102
17. Satoh T., Furuta K., Tomokiyo K., Namura S., Nakatsuka D., Sugie Y., Ishikawa Y., Hatanaka H., Suzuki M., and Watanabe Y. Neurotrophic actions of novel compounds designed from cyclopentenone prostaglandins. J. Neurochem. 77 (2001) 50-62
18. Satoh T., Okamoto S.I., Cui J., Watanabe Y., Furuta K., Suzuki M., Tohyama K., and Lipton S.A. Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic [correction of electrophillic] phase II inducers. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 768-773
19. 2: the anti-inflammatory prostaglandin?. Clin. Immunol. 114 (2005) 100-109
20. Sutliff R.L., Hoying J.B., Kadambi V.J., Kranias E.G., and Paul R.J. Phospholamban is present in endothelial cells and modulates endothelium-dependent relaxation. Evidence from phospholamban gene-ablated mice. Circ. Res. 84 (1999) 360-364
21. Suzuki M., Kiho T., Tomokiyo K., Furuta K., Fukushima S., Takeuchi Y., Nakanishi M., and Noyori R. Rational design of antitumor prostaglandins with high biological stability. J. Med. Chem. 41 (1998) 3084-3090
22. Takamatsu H., Tatsumi M., Nitta S., Ichise R., Muramatsu K., Iida M., Nishimura S., and Umemura K. Time courses of progress to the chronic stage of middle cerebral artery occlusion models in rats. Exp. Brain Res. 146 (2002) 95-102
23. Umemura K., Wada K., Uematsu T., and Nakashima M. Evaluation of the combination of a tissue-type plasminogen activator, SUN9216, and a thromboxane A2 receptor antagonist, vapiprost, in a rat middle cerebral artery thrombosis model. Stroke 24 (1993) 1077-1082
24. Urade Y., and Hayaishi O. Prostaglandin D synthase: structure and function. Vitam. Horm. 58 (2000) 89-120
25. Urade Y., Ujihara M., Horiguchi Y., Ikai K., and Hayaishi O. The major source of endogenous prostaglandin D2 production is likely antigen-presenting cells. Localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues. J. Immunol. 143 (1989) 2982-2989
26. 2+ homeostasis and neuronal death. J. Cell. Mol. Med. 7 (2003) 351-361
27. Wright D.H., Metters K.M., Abramovitz M., and Ford-Hutchinson A.W. Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist. Br. J. Pharmacol. 123 (1998) 1317-1324
28. Wuytack F., Raeymaekers L., and Missiaen L. Molecular physiology of the SERCA and SPCA pumps. Cell Calcium 32 (2002) 279-305
29. Zhao X., Ou Z., Grotta J., Waxham N., and Aronowski J. Peroxisome-proliferator-activated receptor-gamma (PPARγ) activation protects neurons from NMDA excitotoxicity. Brain Res. 1073-1074 (2006) 460-469